# Alloy Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alloy-health

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.myalloy.com
- Total disclosed funding: $18M
- Latest round: Series A (Oct 17, 2024)
- Investors on record: 4

## About

Alloy Health, Inc. is a telehealth company specializing in menopause-related healthcare, offering personalized solutions such as Menopausal Hormone Treatment (MHT) and weight management programs to improve women's health.Founded in 2021 and headquartered in New York, US, Alloy Health, Inc. provides telehealth services targeting menopause care. The company has completed 2 funding rounds, with the latest being a Series A round in October 2024, raising USD 14.905 mn led by Kairos, alongside investors Emmeline Ventures, Amboy Street Ventures, and PACE Healthcare Capital. The current valuation is USD 142.780 mn.Alloy offers a comprehensive suite of menopause-related healthcare solutions, focusing on Menopausal Hormone Treatment (MHT) and weight management programs. Their offerings include doctor-prescribed medications such as Estradiol, progesterone, and compounded weight care solutions. Alloy aims to alleviate menopausal symptoms like hot flashes and mood swings, catering to women in the perimenopausal and postmenopausal stages across all 50 states in the U.S. through easy access and personalized treatment plans delivered directly to customers' doors.Alloy's revenue model is based on direct-to-consumer transactions, providing a subscription-like service for ongoing access to prescribed treatments and consultations with menopause-specialized healthcare professionals. Customers complete an intake form to create tailored treatment plans, resulting in a recurring revenue stream as they maintain their prescriptions. The MHT options and weight management solutions drive revenue generation, addressing health challenges faced by women during menopause with pricing aligned to specific treatment needs.In October 2024, Alloy Health, Inc. raised USD 14.91 million in Series A funding, which will be used to expand its product offerings beyond menopause symptom treatment into hair, skin, and sexual wellness for women in midlife. This growth strategy aims to address a broader spectrum of health needs in future markets.

## Funding rounds

- Series A, Oct 17, 2024, $15M — Kairos, Amboy Street Ventures, PACE Healthcare Capital, Emmeline Ventures
- Seed, Oct 14, 2021, $3.3M — Kairos, PACE Healthcare Capital

## Investors

- Kairos (https://capitalatlas.ai/funds/kairos) — Seed, Series A
- PACE Healthcare Capital (https://capitalatlas.ai/funds/pace-healthcare-capital) — Seed, Series A
- Amboy Street Ventures (https://capitalatlas.ai/funds/amboy-street-ventures) — Series A
- Emmeline Ventures (https://capitalatlas.ai/funds/emmeline-ventures) — Series A